4th Quarter - Report

STUMPTOWN STRATEGIES for PRIME THERAPEUTICS

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Monitoring PBM Legislation Senate Finance Committee PBM Framework - Delinking S.1339 - The Pharmacy Benefit Manager Reform - Delinking H.R. 3561 - Patient Act - Transparency Requirements & Spread Pricing H.R. 4507 - Health DATA Act - Provisions related to plan fiduciaries access to data H.R.5378 - The Lower Cost More Transparency Act - Sections 105, 106, 109, 110, 202, 401, 402 & 403-provisions related to PBM transparency and disclosure

LobbyistCovered position, as disclosed
BLAIR LARKINS Staff Assistant, Greg Walden 2005-2006, Executive Assistant, Greg Walden 2006-2001

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4507 (118th), S. 1339 (118th), H.R. 5378 (118th), H.R. 3561 (118th)

Pharmacy PHA

Monitoring PBM Legislation Pharmacist Audit & Compensation Transparency Act HR 9096 Pharmacists Fight Back Act - a bill to establish pharmacy payment and reimbursement by PBMs.

LobbyistCovered position, as disclosed
BLAIR LARKINS Staff Assistant, Rep. Greg Walden (2005-2006); Executive Assistant, Rep. Greg Walden (2006-2011)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 9096 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.